Skip header and navigation

1 records – page 1 of 1.

measles-polio-hepatitis A vaccine vial

https://mhc.andornot.com/en/permalink/artifact4297
Dates
1975
circa 1975
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseasesvac
Vaccination
Accession Number
000001471 a-c
Description
A cylindrical glass vial (b) inside a cardboard box (a) with a paper leaflet (c); vial is stopped with a rubber stopper and sealed with a metal cap moulded over the neck and lip; a plastic cap covers the metal cap such that when it is pulled off it breaks the seal on the metal cap; vial has a paper…
  5 images  
Accession Number
000001471 a-c
Collection
Parke-Davis Collection
Category
Pharmacy and Drug Artifacts
Vaccination
Classification
Pharmacy, Infectious Diseasesvac
Vaccination
MeSH Heading
Immunization, Passive
Vaccination
Hepatitis A -- prevention & control
Measles -- prevention & control
Poliomyelitis Vaccine
MM= Drug Packaging -- container -- vial
Description
A cylindrical glass vial (b) inside a cardboard box (a) with a paper leaflet (c); vial is stopped with a rubber stopper and sealed with a metal cap moulded over the neck and lip; a plastic cap covers the metal cap such that when it is pulled off it breaks the seal on the metal cap; vial has a paper label around its circumference and is full of liquid.
Number Of Parts
3
Part Names
a - box - Size: Length 5.0 cm x Width 2.1 cm x Depth 2.1 cm
b - vial - Size: Length 3.4 cm x Diam. 1.5 cm
c - leaflet (unfolded) - Size: Length 30.0 cm x Width 17.7 cm
Provenance
Collected by Parke-Davis
Maker
Parke, Davis & Co.
Site Made (City)
Detroit
Site Made (State)
Michigan
Site Made (Country)
United States of America
Dates
1975
circa 1975
Date Remarks
Based on expiry date
Material
paper: white
ink: blue; black
cardboard: blue; white
glass: clear
plastic: blue
metal: silver
rubber: pink
Inscriptions
(a) Top: "2 ML. NDC 71-1316-1 // IMMU-G® // GAMMA GLOBULIN (HUMAN) // For prophylaxis of infectious hepatitis, for use // with measles vaccine, for modification and preven- // tion of measles, and other infections in which this // product is of value. See package insert. [printed] // L/A [handwritten] // PARKE-DAVIS [printed]"; front: "[illeg.] // Immu-G varies in color from amber to red-brown, // but this is not related to potency or stability. // This lot is recommended for poliomyelitis; it is // suitable for use with Measles Virus Vaccine, Live, // Attenuated. // Store at 2° to 8° C. (36° to 46° F.). // Preservative: 1:10,000 thimerosal (mercury deriv.). // Parke, Davis & Co. Detroit, Mich. 48232 U.S.A."; bottom: "2 ML. NDC 71-1316-1 // IMMUNE SERUM GLOBULIN // (HUMAN), U.S.P. // No U.S. standard of potency for viral // hepatitis antibodies. // U.S. Lic. No. 1. Canadian Lic. No. 1. // PARKE-DAVIS"; back: "DOSE – Intramuscularly only. For hepatitis prophy- // laxis, 0.01 to 0.05 ml. per lb.; for preventing // measles, 0.1 ml. per lb.; for modifying measles, // 0.02 ml. per lb. See package insert for additional // information including recommended dosage for // modifying measles vaccine reactions, for polio- // myelitis, rubella, varicella, supportative therapy in // bacterial infections, and dysgammaglobulinemia. // DO NOT GIVE INTRAVENOUSLY"; right side: "2 ML. // IMMU-G // GAMMA GLOBULIN // (HUMAN) // Exp. Date and Lot [printed] // DEC. 10, 1975 // 901530A [stamped]"; left side: "2 ML. // IMMU-G // GAMMA GLOBULIN // (HUMAN) // Parke, Davis & Co. // Stock 4-618-1 // NDC 71-1316-1"; (b) front: "2 ml. Bio. 618 // IMMU-G® // IMMUNE SSERUM GLOBULIN // (HUMAN), U.S.P. // Usual Dose: 0.01 ml to 0.1 ml. per // lb. intramuscularly. See insert. // Exp. Date: [printed] Dec. 10, 1975 [stamped] // U.S. Lic. No. 1. Lot [printed] 901530 [stamped] // Parke, Davis & Co., Detroit, Mich., U.S.A. [printed]"; top: "FLIP // OFF [embossed]"; (c) "AHFS Category 80:04 // IMMU-G® // (IMMUNE SERUM GLOBULIN [HUMAN] [square brackets in text], U.S.P.) // GAMMA GLOBULIN (HUMAN) // PARKE-DAVIS // DESCRIPTION // [text follows] // INDICATIONS // [text follows] // ADVERSE REACTIONS // [text follows] // DOSAGE AND ADMINISTRATION // [text follows] // HOW SUPPLIED // [text follows] // REFERENCES // [text follows] // 121 856500 // PARKE-DAVIS // DETROIT, MICHIGAN 48232 U.S.A. // L-95A ML // Issued Nov. 1972"
Permanent Location
Storage Room 0010
0010-A3-5 Row H
Temporary Location
On exhibit 100TH Anniversary of Public Health Canada, Ottawa L-2019-7 27 Nov – 2 Dec 2019
Condition Remarks
Box dented, scuffed, water damaged, ink has migrated on front ; no apparent problems with vial or leaflet
Copy Type
Original
Reference Comments
typesofvaccines.com
Research Facts
Used to boost one's immunity by injecting immunoglobins into the blood. Also used to prevent miscarriage in women who have a negative blood type but whose foetus has a positive blood type.
Images
Less detail